Extranodal NK-T-cell lymphoma overview: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 3: Line 3:


==Overview==
==Overview==
'''Extranodal NK-T-cell lymphoma''' is a type of [[lymphoma]].<ref name="pmid16380410">{{cite journal |author=Lee J, Suh C, Park YH, ''et al'' |title=Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study |journal=J. Clin. Oncol. |volume=24 |issue=4 |pages=612–8 |year=2006 |month=February |pmid=16380410 |doi=10.1200/JCO.2005.04.1384 |url=http://www.jco.org/cgi/pmidlookup?view=long&pmid=16380410}}</ref><ref name="pmid15963893">{{cite journal |author=Lee J, Park YH, Kim WS, ''et al'' |title=Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy |journal=Eur. J. Cancer |volume=41 |issue=10 |pages=1402–8 |year=2005 |month=July |pmid=15963893 |doi=10.1016/j.ejca.2005.03.010 |url=http://linkinghub.elsevier.com/retrieve/pii/S0959-8049(05)00218-2}}</ref><ref name="pmid19041057">{{cite journal |author=Lee J, Au WY, Park MJ, ''et al'' |title=Autologous hematopoietic stem cell transplantation in extranodal natural killer/T cell lymphoma: a multinational, multicenter, matched controlled study |journal=Biol. Blood Marrow Transplant. |volume=14 |issue=12 |pages=1356–64 |year=2008 |month=December |pmid=19041057 |doi=10.1016/j.bbmt.2008.09.014 |url=http://linkinghub.elsevier.com/retrieve/pii/S1083-8791(08)00405-9}}</ref>
'''Extranodal NK-T-cell lymphoma''' is a type of [[lymphoma]].<ref name="pmid16380410">{{cite journal |author=Lee J, Suh C, Park YH, ''et al'' |title=Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study |journal=J. Clin. Oncol. |volume=24 |issue=4 |pages=612–8 |year=2006 |month=February |pmid=16380410 |doi=10.1200/JCO.2005.04.1384 |url=http://www.jco.org/cgi/pmidlookup?view=long&pmid=16380410}}</ref> <ref name="pmid15963893">{{cite journal |author=Lee J, Park YH, Kim WS, ''et al'' |title=Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy |journal=Eur. J. Cancer |volume=41 |issue=10 |pages=1402–8 |year=2005 |month=July |pmid=15963893 |doi=10.1016/j.ejca.2005.03.010 |url=http://linkinghub.elsevier.com/retrieve/pii/S0959-8049(05)00218-2}}</ref> <ref name="pmid19041057">{{cite journal |author=Lee J, Au WY, Park MJ, ''et al'' |title=Autologous hematopoietic stem cell transplantation in extranodal natural killer/T cell lymphoma: a multinational, multicenter, matched controlled study |journal=Biol. Blood Marrow Transplant. |volume=14 |issue=12 |pages=1356–64 |year=2008 |month=December |pmid=19041057 |doi=10.1016/j.bbmt.2008.09.014 |url=http://linkinghub.elsevier.com/retrieve/pii/S1083-8791(08)00405-9}}</ref>
It is called "extranodal" to emphasize that the location is not in the [[lymph node]]. It is sometimes further qualified as "nasal type".
It is called "extranodal" to emphasize that the location is not in the [[lymph node]]. It is sometimes further qualified as "nasal type".
It can be associated with [[Epstein Barr virus]].<ref name="pmid11727268">{{cite journal |author=Stadlmann S, Fend F, Moser P, Obrist P, Greil R, Dirnhofer S |title=Epstein-Barr virus-associated extranodal NK/T-cell lymphoma, nasal type of the hypopharynx, in a renal allograft recipient: case report and review of literature |journal=Hum. Pathol. |volume=32 |issue=11 |pages=1264–8 |year=2001 |month=November |pmid=11727268 |doi= |url=http://linkinghub.elsevier.com/retrieve/pii/S0046817701559572}}</ref><ref name="pmid19033930">{{cite journal |author=Ferenczi K, Summers P, Aubert P, ''et al'' |title=A case of CD30+ nasal natural killer/T-cell lymphoma |journal=Am J Dermatopathol |volume=30 |issue=6 |pages=567–71 |year=2008 |month=December |pmid=19033930 |doi=10.1097/DAD.0b013e318184bc3f |url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00000372-200812000-00006}}</ref>
It can be associated with [[Epstein Barr virus]]. <ref name="pmid11727268">{{cite journal |author=Stadlmann S, Fend F, Moser P, Obrist P, Greil R, Dirnhofer S |title=Epstein-Barr virus-associated extranodal NK/T-cell lymphoma, nasal type of the hypopharynx, in a renal allograft recipient: case report and review of literature |journal=Hum. Pathol. |volume=32 |issue=11 |pages=1264–8 |year=2001 |month=November |pmid=11727268 |doi= |url=http://linkinghub.elsevier.com/retrieve/pii/S0046817701559572}}</ref> <ref name="pmid19033930">{{cite journal |author=Ferenczi K, Summers P, Aubert P, ''et al'' |title=A case of CD30+ nasal natural killer/T-cell lymphoma |journal=Am J Dermatopathol |volume=30 |issue=6 |pages=567–71 |year=2008 |month=December |pmid=19033930 |doi=10.1097/DAD.0b013e318184bc3f |url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00000372-200812000-00006}}</ref>


[[RNAi]] against [[EBNA1]] has been proposed as a possible treatment.<ref name="pmid18769118">{{cite journal |author=Ian MX, Lan SZ, Cheng ZF, Dan H, Qiong LH |title=Suppression of EBNA1 expression inhibits growth of EBV-positive NK/T cell lymphoma cells |journal=Cancer Biol. Ther. |volume=7 |issue=10 |pages=1602–6 |year=2008 |month=October |pmid=18769118 |doi= |url=http://www.landesbioscience.com/journals/cbt/abstract.php?id=6564}}</ref>
[[RNAi]] against [[EBNA1]] has been proposed as a possible treatment. <ref name="pmid18769118">{{cite journal |author=Ian MX, Lan SZ, Cheng ZF, Dan H, Qiong LH |title=Suppression of EBNA1 expression inhibits growth of EBV-positive NK/T cell lymphoma cells |journal=Cancer Biol. Ther. |volume=7 |issue=10 |pages=1602–6 |year=2008 |month=October |pmid=18769118 |doi= |url=http://www.landesbioscience.com/journals/cbt/abstract.php?id=6564}}</ref>

Revision as of 20:31, 12 February 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Extranodal NK-T-cell lymphoma is a type of lymphoma.[1] [2] [3] It is called "extranodal" to emphasize that the location is not in the lymph node. It is sometimes further qualified as "nasal type". It can be associated with Epstein Barr virus. [4] [5]

RNAi against EBNA1 has been proposed as a possible treatment. [6]

  1. ↑ Lee J, Suh C, Park YH; et al. (2006). "Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study". J. Clin. Oncol. 24 (4): 612–8. doi:10.1200/JCO.2005.04.1384. PMID 16380410. Unknown parameter |month= ignored (help)
  2. ↑ Lee J, Park YH, Kim WS; et al. (2005). "Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy". Eur. J. Cancer. 41 (10): 1402–8. doi:10.1016/j.ejca.2005.03.010. PMID 15963893. Unknown parameter |month= ignored (help)
  3. ↑ Lee J, Au WY, Park MJ; et al. (2008). "Autologous hematopoietic stem cell transplantation in extranodal natural killer/T cell lymphoma: a multinational, multicenter, matched controlled study". Biol. Blood Marrow Transplant. 14 (12): 1356–64. doi:10.1016/j.bbmt.2008.09.014. PMID 19041057. Unknown parameter |month= ignored (help)
  4. ↑ Stadlmann S, Fend F, Moser P, Obrist P, Greil R, Dirnhofer S (2001). "Epstein-Barr virus-associated extranodal NK/T-cell lymphoma, nasal type of the hypopharynx, in a renal allograft recipient: case report and review of literature". Hum. Pathol. 32 (11): 1264–8. PMID 11727268. Unknown parameter |month= ignored (help)
  5. ↑ Ferenczi K, Summers P, Aubert P; et al. (2008). "A case of CD30+ nasal natural killer/T-cell lymphoma". Am J Dermatopathol. 30 (6): 567–71. doi:10.1097/DAD.0b013e318184bc3f. PMID 19033930. Unknown parameter |month= ignored (help)
  6. ↑ Ian MX, Lan SZ, Cheng ZF, Dan H, Qiong LH (2008). "Suppression of EBNA1 expression inhibits growth of EBV-positive NK/T cell lymphoma cells". Cancer Biol. Ther. 7 (10): 1602–6. PMID 18769118. Unknown parameter |month= ignored (help)
Retrieved from "https://www.wikidoc.org/index.php?title=Extranodal_NK-T-cell_lymphoma_overview&oldid=1067404"